{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:12:01Z","timestamp":1773094321344,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T00:00:00Z","timestamp":1219276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AGE"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s11357-008-9070-3","type":"journal-article","created":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T09:09:33Z","timestamp":1219223373000},"page":"283-291","source":"Crossref","is-referenced-by-count":42,"title":["High-dose statin use does not impair aerobic capacity or skeletal muscle function in older adults"],"prefix":"10.1007","volume":"30","author":[{"given":"Tinna","family":"Traustad\u00f3ttir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthoney A.","family":"Stock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Mitchell","family":"Harman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,21]]},"reference":[{"key":"9070_CR1","volume-title":"Guidelines for exercise testing and prescription","author":"American College of Sports Medicine","year":"1991","unstructured":"American College of Sports Medicine (1991) Guidelines for exercise testing and prescription, 4th edn. Lea & Febiger, Philadelphia","edition":"4"},{"key":"9070_CR2","first-page":"406","volume-title":"Essentials of strength training and conditioning","author":"TR Baechle","year":"2000","unstructured":"Baechle TR, Earle RW, Wathen D (2000) Resistance training. In: Baechle TR, Earle RW (eds) Essentials of strength training and conditioning. 2nd edn. Human Kinetics, Champaign, pp 406\u2013409","edition":"2"},{"key":"9070_CR3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","volume":"19","author":"E Bruckert","year":"2006","unstructured":"Bruckert E, Hayem G, DeJager S, Yau C, Begaud B (2006) Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2014The PRIMO Study. Cardiovasc Drugs Ther 19:403\u2013414","journal-title":"Cardiovasc Drugs Ther"},{"key":"9070_CR4","doi-asserted-by":"crossref","unstructured":"Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R et al (2004) Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:1495\u20131504","DOI":"10.1056\/NEJMoa040583"},{"key":"9070_CR5","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2006.12.063","volume":"99","author":"G Caso","year":"2007","unstructured":"Caso G, Kelly P, McNurian MA, Lawson WE (2007) Effect of Coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol 99:1409\u20131412","journal-title":"Am J Cardiol"},{"key":"9070_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1249\/JES.0b013e31803e88e9","volume":"35","author":"K Conley","year":"2007","unstructured":"Conley K, Jubrias S, Amara CE, Marcinek DJ (2007) Mitochondrial dysfunction: Impact on exercise performance and cellular aging. Exerc Sport Sci Rev 35:43\u201349","journal-title":"Exerc Sport Sci Rev"},{"key":"9070_CR7","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.jacc.2007.01.067","volume":"49","author":"MH Davidson","year":"2007","unstructured":"Davidson MH, Robinson JG (2007) Safety of aggressive lipid management. J Am Coll Cardiol 49:1753\u20131762","journal-title":"J Am Coll Cardiol"},{"key":"9070_CR8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1445-5994.1995.tb01912.x","volume":"25","author":"J England","year":"1995","unstructured":"England J, Walsh J, Stewart P, Boyd I, Rohan A, Halmagyi G (1995) Mitochondrial myopathy developing on treatment with the HMG CoA reductase inhibitors\u2014simvastatin and pravastatin. Aust N Z J Med 25:374\u2013375","journal-title":"Aust N Z J Med"},{"key":"9070_CR9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1023\/B:CARD.0000015861.26111.ab","volume":"17","author":"S Franc","year":"2003","unstructured":"Franc S, DeJager S, Bruckert E, Chauvenet M, Giral P, Turpin G (2003) A comprehensive description of muscle symptoms associated with lipid lowering drugs. Cardiovasc Drugs Ther 17:459\u2013465","journal-title":"Cardiovasc Drugs Ther"},{"key":"9070_CR10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001648-200109000-00017","volume":"12","author":"D Gaist","year":"2001","unstructured":"Gaist D, Rodriguez L, Huerta C, Hallas J, Sindrup S (2001) Lipid-lowering drugs and risk of myopathy: a population-based follow-up study. Epidmiology 12:565\u2013569","journal-title":"Epidmiology"},{"key":"9070_CR11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM199701303360503","volume":"336","author":"M Johannesson","year":"1997","unstructured":"Johannesson M, J\u00f6nsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H (1997) Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N Engl J Med 336:332\u2013336","journal-title":"N Engl J Med"},{"key":"9070_CR12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-5793(98)01712-8","volume":"443","author":"J Kaikkonen","year":"1999","unstructured":"Kaikkonen J, Nyyss\u00f6nen K, Tuomainen T-P, Ristonmaa U, Salonen JT (1999) Determinants of plasma coenzyme Q10 in humans. FEBS Lett 443:163\u2013166","journal-title":"FEBS Lett"},{"key":"9070_CR13","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1152\/jappl.1991.71.5.2004","volume":"71","author":"W Kohrt","year":"1991","unstructured":"Kohrt W, Malley M, Coggan A, Spina R, Ogawa T, Ehsani A et al (1991) Effects of gender, age, and fitness level on response of VO2 max to training in 60\u201371\u00a0yr olds. J Appl Physiol 71:2004\u20132011","journal-title":"J Appl Physiol"},{"key":"9070_CR14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/biof.5520090215","volume":"9","author":"A Lass","year":"1999","unstructured":"Lass A, Kwong LK, Sohal RS (1999) Mitochondrial coenzyme Q content and aging. Biofactors 9:199\u2013205","journal-title":"Biofactors"},{"key":"9070_CR15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.crd.0000154790.42283.a1","volume":"13","author":"JJ Nawarskas","year":"2005","unstructured":"Nawarskas JJ (2005) HMG-CoA reductase inhibitors and coenzyme Q10. Cardiol Rev 13:76\u201379","journal-title":"Cardiol Rev"},{"key":"9070_CR16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","volume":"291","author":"S Nissen","year":"2004","unstructured":"Nissen S, Tuzcu E, Schoenhagen P, Brown BG, Ganz P, Vogel R et al (2004) Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. A randomized controlled trial. JAMA 291:1071\u20131080","journal-title":"JAMA"},{"key":"9070_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","volume":"352","author":"S Nissen","year":"2005","unstructured":"Nissen S, Tuzcu E, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J et al (2005) Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 352:29\u201338","journal-title":"N Engl J Med"},{"key":"9070_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-511X-6-7","volume":"6","author":"J Oh","year":"2007","unstructured":"Oh J, Ban MR, Miskie BA, Pollex RL, Hegele RA (2007) Genetic determinants of static intolerance. Lipids Health Dis 6:7\u201311","journal-title":"Lipids Health Dis"},{"key":"9070_CR19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1345\/aph.10228","volume":"35","author":"MA Omar","year":"2001","unstructured":"Omar MA, Wilson JP, Cox TS (2001) Rhabdomyolysis and HMG-CoA reductase inhibitors. Ann Pharmacother 35:1096\u20131107","journal-title":"Ann Pharmacother"},{"key":"9070_CR20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","volume":"78","author":"H Paiva","year":"2005","unstructured":"Paiva H, Thelen KM, Van Coster R, Smet J, De Paepe B, Mattila KM et al (2005) High-dose statins and skeletal muscle metabolism in humans: A randomized, controlled trial. Clin Pharmacol Ther 78:60\u201368","journal-title":"Clin Pharmacol Ther"},{"key":"9070_CR21","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.str.0000034125.94759.41","volume":"33","author":"RC Pasternak","year":"2002","unstructured":"Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C (2002) ACC\/AHA\/NHLBI Clinical Advisory on the Use and Safety of Statins. Stroke 33:2337\u20132341","journal-title":"Stroke"},{"key":"9070_CR22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0002-9149(01)01449-7","volume":"87","author":"TR Pedersen","year":"2001","unstructured":"Pedersen TR (2001) Pro and con: low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid management. Am J Cardiol 87:8\u201312","journal-title":"Am J Cardiol"},{"key":"9070_CR23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.1082889","volume":"300","author":"KF Petersen","year":"2007","unstructured":"Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL et al (2007) Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 300:1140\u20131142 doi: 10.1126\/science.1082889","journal-title":"Science"},{"key":"9070_CR24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","volume":"137","author":"PS Phillips","year":"2002","unstructured":"Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ et al (2002a) Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med 137:581\u2013585","journal-title":"Ann Intern Med"},{"key":"9070_CR25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","volume":"137","author":"PS Phillips","year":"2002","unstructured":"Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ et al (2002b) Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med 137:581\u2013585","journal-title":"Ann Intern Med"},{"key":"9070_CR26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","volume":"137","author":"PS Phillips","year":"2002","unstructured":"Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ et al (2002c) Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med 137:581\u2013585","journal-title":"Ann Intern Med"},{"key":"9070_CR27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.atherosclerosis.2004.06.014","volume":"177","author":"PS Phillips","year":"2004","unstructured":"Phillips PS, Phillips CT, Sullivan MJ, Naviaux RK, Haas RH (2004) Statin myotoxicity is associated with changes in the cardiopulmonary function. Atherosclerosis 177:183\u2013188","journal-title":"Atherosclerosis"},{"key":"9070_CR28","first-page":"519","volume":"15","author":"LL Ploutz-Snyder","year":"2001","unstructured":"Ploutz-Snyder LL, Giamis EL (2001) Orientation and familiarization to 1RM strength testing in old and young women. J Strength Cond Res 15:519\u2013523","journal-title":"J Strength Cond Res"},{"key":"9070_CR29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/sj.clpt.6100124","volume":"81","author":"BA Schick","year":"2007","unstructured":"Schick BA, Laaksonen R, Frohlich JJ, Paiva H, Lehtimaki T, Humphries KH et al (2007) Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin. Clin Pharmacol Ther 81:650\u2013653","journal-title":"Clin Pharmacol Ther"},{"key":"9070_CR30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0021-9150(98)00310-4","volume":"143","author":"H Sinzinger","year":"1999","unstructured":"Sinzinger H, Schmid P, O\u2019Grady J (1999) Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment. Atherosclerosis 143:459\u2013460","journal-title":"Atherosclerosis"},{"key":"9070_CR31","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0026-0495(97)90218-3","volume":"46","author":"PD Thompson","year":"1997","unstructured":"Thompson PD, Zmuda JM, Domalik LJ, Zimet RJ, Staggers J, Guyton JR (1997) Lovastatin increases exercise-induced skeletal muscle injury. Metabolism 46:1206\u20131210","journal-title":"Metabolism"},{"key":"9070_CR32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbamem.2003.11.012","volume":"1660","author":"M Turunen","year":"2004","unstructured":"Turunen M, Olsson J, Dallner G (2004) Metabolism and function of coenzyme Q. Biochim Biophys Acta 1660:171\u2013199","journal-title":"Biochim Biophys Acta"}],"container-title":["AGE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-008-9070-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11357-008-9070-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-008-9070-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T14:17:36Z","timestamp":1559398656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11357-008-9070-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,21]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["9070"],"URL":"https:\/\/doi.org\/10.1007\/s11357-008-9070-3","relation":{},"ISSN":["0161-9152","1574-4647"],"issn-type":[{"value":"0161-9152","type":"print"},{"value":"1574-4647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,21]]}}}